Gene expression profiles induced by growth factors in in vitro cultured osteoblasts

Bone and Joint Research

Volumn 3, Issue 7, 2014, Pages 236-240

  Robubi, A ^a,b   Berger, C ^a   Schmid, M ^a,b   Huber, K R ^a,b   Engel, A ^a   Krugluger, W ^a,b  

^a DANUBE HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Alkaline phosphatase; Osteoblasts; SMAD; Tissue engineering; Wnt

Indexed keywords

EID: 84984904227     PISSN: None     EISSN: 20463758     Source Type: Journal    
DOI: 10.1302/2046-3758.37.2000231     Document Type: Article

References (31)

1. Schmidt-Rohlfing B, Tzioupis C, Menzel CL, Pape HC. Tissue engineering of bone tissue. Principles and clinical applications. Unfallchirurg 2009;112:785-794;quiz795. [Article in German].
2. Stern AR, Stern MM, Van Dyke ME, et al. Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice. Biotechniques 2012;52:361-373.
3. Kawakami Y, Li M, Alev C, et al. Local transplantation of ex vivo expanded bone marrow-derived CD34-positive cells accelerates fracture healing. Cell Transplant 2012;21:2689-2709.
4. Czekanska EM, Stoddart MJ, Richards RG, Hayes JS. In search of an osteoblast cell model for in vitro research. Eur Cell Mater 2012;24:1-17.
5. Aubin JE. Advances in the osteoblast lineage. Biochem Cell Biol 1998;76:899-910.
6. Cheng SL, Lecanda F, Davidson MK, et al. Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation. J Bone Miner Res 1998;13:633-644.
7. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-319.
8. Liu TM, Lee EH. Transcriptional regulatory cascades in Runx2-dependent bone development. Tissue Eng Part B Rev 2013;19:254-263.
9. Merle B, Garnero P. The multiple facets of periostin in bone metabolism. Osteoporos Int 2012;23:1199-1212.
10. Deng FY, Tan LJ, Shen H, et al. SNP rs6265 regulates protein phosphorylation and osteoblast differentiation and influences BMD in humans. J Bone Miner Res 2013;28:2498-2507.
11. Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem 2005;280:41342-41351.
12. Lambertini E, Franceschetti T, Torreggiani E, et al. SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts. BMC Mol Biol 2010;11:13.
13. Luo S, Lee AS. Requirement of the p38 mitogen-activated protein kinase signalling pathway for the induction of the 78 kDa glucose-regulated protein/immunoglobulin heavy-chain binding protein by azetidine stress: activating transcription factor 6 as a target for stress-induced phosphorylation. Biochem J 2002;366(Pt3):787-795.
14. Zhang Y, Feng XH, Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 1998;394:909-913.
15. Won KY, Kim YW, Park YK. Expression of Smad and its signalling cascade in osteosarcoma. Pathology 2010;42:242-247.
16. Sömjen D, Kaye AM. Stimulation by insulin-like growth factor-I of creatine kinase activity in skeletal-derived cells and tissues of male and female rats. J Endocrinol 1994;143:251-259.
17. Krattinger N, Applegate LA, Biver E, Pioletti DP, Caverzasio J. Regulation of proliferation and differentiation of human fetal bone cells. Eur Cell Mater 2011;21:46-58.
18. Bard DR, Dickens MJ, Smith AU, Zarek JM. Isolation of living cells from mature mammalian bone. Nature 1972;236:314-315.
19. Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996;10:1580-1594.
20. Tanaka H, Wakisaka A, Ogasa H, Kawai S, Liang CT. Effect of IGF-I and PDGF administered in vivo on the expression of osteoblast-related genes in old rats. J Endocrinol 2002;174:63-70.
21. Saitoh T, Katoh M. Molecular cloning and characterization of human WNT5B on chromosome 12p13.3 region. Int J Oncol 2001;19:347-351.
22. Wong BR, Rho J, Arron J, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 1997;272:25190-25194.
23. Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997;390:175-179.
24. Xiao SM, Gao Y, Cheung CL, et al. Association of CDX1 binding site of periostin gene with bone mineral density and vertebral fracture risk. Osteoporos Int 2012;23:1877-1887.
25. Szulc P, Garnero P, Marchand F, Duboeuf F, Delmas PD. Biochemical markers of bone formation reflect endosteal bone loss in elderly men - MINOS study. Bone 2005;36:13-21.
26. Kalajzic I, Staal A, Yang WP, et al. Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem 2005;280:24618-24626.
27. Nohe A, Hassel S, Ehrlich M, et al. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 2002;277:5330-5338.
28. Kimura N, Matsuo R, Shibuya H, Nakashima K, Taga T. BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem 2000;275:17647-17652.
29. Raucci A, Bellosta P, Grassi R, Basilico C, Mansukhani A. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. J Cell Physiol 2008;215:442-451.
30. Park JK, Jang H, Hwang S, et al. ER stress-inducible ATF3 suppresses BMP2-induced ALP expression and activation in MC3T3-E1 cells. Biochem Biophys Res Commun 2014;443:333-338.
31. Li P, Bai Y, Yin G, et al. Synergistic and sequential effects of BMP-2, bFGF and VEGF on osteogenic differentiation of rat osteoblasts. J Bone Miner Metab 2013 (Epub).